Cilia Malfunctions May Play Key Role in ALS
Tiny ‘Antennas’ May Hold Key to Unlocking ALS Treatments
Scientists Discover Link Between Cilia Malfunctions and Motor Neuron Death
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating neurodegenerative disease that robs individuals of their ability to move, speak, and eventually breathe. With an average life expectancy of just two to five years after diagnosis, and no known cure, ALS remains a formidable medical challenge.
Now, groundbreaking research from KU Leuven and the VIB Center for Brain Research offers a glimmer of hope. Scientists have uncovered a potential link between ALS and tiny, hair-like structures on cells called cilia.These microscopic “antennas” play a crucial role in receiving and processing vital signals, and their malfunction appears to contribute to the death of motor neurons in ALS.
“We discovered that mutations in a gene called C21orf2 disrupt the formation and structure of primary cilia in motor neurons,” explains Mathias De Decker, lead author of the study published in the journal Brain. “This damage prevents the cilia from functioning properly, disrupting a critical signaling pathway known as sonic hedgehog (Shh).”
The Shh pathway is essential for the health and survival of motor neurons. It enables these cells to form strong connections with muscles, known as neuromuscular junctions. Without these connections,muscles weaken and atrophy,leading to the debilitating symptoms of ALS.
Remarkably, the researchers found that restoring the levels of C21orf2 in damaged cells repaired the cilia and reactivated the Shh pathway, allowing the nerve cells to reconnect with muscles.This finding is particularly significant because similar cilia problems were also observed in motor neurons from ALS patients with mutations in C9orf72, one of the most common genetic causes of ALS. This suggests that cilia malfunctions may be a widespread factor in the disease, regardless of the specific genetic mutation involved.
“These findings open up exciting new avenues for ALS research and treatment,” says Prof. Philip Van Damme. “Targeting cilia malfunctions could potentially slow or even halt the progression of this devastating disease.”
While further research is needed to fully understand the role of cilia in ALS and develop effective therapies, this breakthrough offers renewed hope for patients and their families. The discovery of a potential therapeutic target brings us one step closer to finding a cure for this relentless disease.
Tiny ‘Antennas’ May Hold Key to unlocking ALS Treatments
Scientists Discover Link Between Cilia Malfunctions and Motor Neuron Death
[CITY, STATE] – A groundbreaking finding from KU Leuven and the VIB Center for Brain Research could pave the way for new treatments for Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Researchers have found a potential link between ALS and tiny hair-like structures called cilia, which act as cellular “antennas” crucial for receiving and processing vital signals.
“We discovered that mutations in a gene called C21orf2 disrupt the formation and structure of primary cilia in motor neurons,” explains Mathias De Decker, lead author of the study published in the journal Brain. “This damage prevents the cilia from functioning properly, disrupting a critical signaling pathway known as sonic hedgehog (Shh).”
The Shh pathway is essential for the health and survival of motor neurons. It allows these cells to form strong connections with muscles, called neuromuscular junctions. Without these connections,muscles weaken and atrophy,leading to the debilitating symptoms of ALS.
Remarkably, the researchers found that restoring C21orf2 levels in damaged cells repaired the cilia and reactivated the Shh pathway, enabling the nerve cells to reconnect with muscles. This finding is significant because similar cilia problems were also observed in motor neurons from ALS patients with mutations in C9orf72, one of the most common genetic causes of ALS.
“These findings open up exciting new avenues for ALS research and treatment,” says Prof. Philip Van Damme. “Targeting cilia malfunctions could possibly slow or even halt the progression of this devastating disease.”